Kratom (Mitragynine) Ingestion Requiring Naloxone Reversal

  • Overbeek D
  • Abraham J
  • Munzer B
N/ACitations
Citations of this article
44Readers
Mendeley users who have this article in their library.

Abstract

Kratom (mitragynine) is a naturally occurring opioid agonist whose use has been escalating. Its suppliers advertise it as a safe alternative for opioids and a safe treatment for opioid-withdrawal symptoms. There has been controversy in the past two years regarding the legal status and lack of regulation surrounding kratom. Currently, kratom is legal and unregulated, leaving users at risk from unpredictable potencies and effects. We present the first case of successful naloxone reversal of opioid toxidrome from recreationally used kratom. We advocate further research and regulation to ensure standardized dosing to protect patients.

Cite

CITATION STYLE

APA

Overbeek, D., Abraham, J., & Munzer, B. (2019). Kratom (Mitragynine) Ingestion Requiring Naloxone Reversal. Clinical Practice and Cases in Emergency Medicine, 3(1), 24–26. https://doi.org/10.5811/cpcem.2018.11.40588

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free